These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32615323)

  • 21. Multiple drivers of the COVID-19 spread: The roles of climate, international mobility, and region-specific conditions.
    Kubota Y; Shiono T; Kusumoto B; Fujinuma J
    PLoS One; 2020; 15(9):e0239385. PubMed ID: 32966315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmission risk of SARS-CoV-2 to healthcare workers -observational results of a primary care hospital contact tracing.
    Canova V; Lederer Schläpfer H; Piso RJ; Droll A; Fenner L; Hoffmann T; Hoffmann M
    Swiss Med Wkly; 2020 Apr; 150():w20257. PubMed ID: 32333603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact Tracing to Manage COVID-19 Spread-Balancing Personal Privacy and Public Health.
    Kapa S; Halamka J; Raskar R
    Mayo Clin Proc; 2020 Jul; 95(7):1320-1322. PubMed ID: 32622440
    [No Abstract]   [Full Text] [Related]  

  • 24. Contact lens use at the time of SARS-CoV-2 pandemic for healthcare workers.
    Bhargava R
    Indian J Med Res; 2020 May; 151(5):392-394. PubMed ID: 32474559
    [No Abstract]   [Full Text] [Related]  

  • 25. [The novel coronavirus covid-19 pandemic].
    Cuestas E
    Rev Fac Cien Med Univ Nac Cordoba; 2020 Mar; 77(1):1-3. PubMed ID: 32238250
    [No Abstract]   [Full Text] [Related]  

  • 26. Modelling the epidemic spread of COVID-19 virus infection in Northern African countries.
    Daw MA; El-Bouzedi AH
    Travel Med Infect Dis; 2020; 35():101671. PubMed ID: 32304743
    [No Abstract]   [Full Text] [Related]  

  • 27. Discovering Correlations between the COVID-19 Epidemic Spread and Climate.
    Lin S; Fu Y; Jia X; Ding S; Wu Y; Huang Z
    Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33138223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding COVID-19 in Nepal.
    Pun SB; Mandal S; Bhandari L; Jha S; Rajbhandari S; Mishra AK; Sharma Chalise B; Shah R
    J Nepal Health Res Counc; 2020 Apr; 18(1):126-127. PubMed ID: 32335607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cluster of Severe Acute Respiratory Syndrome Coronavirus 2 Infections Linked to Music Clubs in Osaka, Japan.
    Sugano N; Ando W; Fukushima W
    J Infect Dis; 2020 Oct; 222(10):1635-1640. PubMed ID: 32840606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France.
    Dimeglio C; Loubes JM; Deporte B; Dubois M; Latour J; Mansuy JM; Izopet J
    J Infect; 2020 Aug; 81(2):318-356. PubMed ID: 32360497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
    Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
    Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covid-19 in the workplace.
    Agius RM; Robertson JFR; Kendrick D; Sewell HF; Stewart M; McKee M
    BMJ; 2020 Sep; 370():m3577. PubMed ID: 32958470
    [No Abstract]   [Full Text] [Related]  

  • 33. [Management guidelines for vulnerable workers and persons and SARS-CoV-2 in Catalonian businesses].
    Grupo de trabajo Grupo de trabajo para la elaboración de criterios para la gestión de personas especialmente vulnerables y trabajadores/as especialmente sensibles frente al SARS-CoV-2 en las empresas de Cataluña.GTPSVTESSARS-CoV-2
    Arch Prev Riesgos Labor; 2020 Apr; 23(2):234-252. PubMed ID: 32320546
    [No Abstract]   [Full Text] [Related]  

  • 34. Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data- and model-driven study.
    Zu J; Li ML; Li ZF; Shen MW; Xiao YN; Ji FP
    Infect Dis Poverty; 2020 Jul; 9(1):83. PubMed ID: 32631426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now?
    Torti C; Mazzitelli M; Trecarichi EM; Darius O
    BMC Infect Dis; 2020 Jun; 20(1):412. PubMed ID: 32536344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Mathematical Model to Investigate the Transmission of COVID-19 in the Kingdom of Saudi Arabia.
    Alshammari FS
    Comput Math Methods Med; 2020; 2020():9136157. PubMed ID: 33062043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 and impact of personal protective equipment use: From occupational to generalized skin care need.
    Atzori L; Ferreli C; Atzori MG; Rongioletti F
    Dermatol Ther; 2020 Jul; 33(4):e13598. PubMed ID: 32415741
    [No Abstract]   [Full Text] [Related]  

  • 38. SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall.
    Anastassopoulou C; Spanakis N; Tsakris A
    Future Microbiol; 2020 Sep; 15():1201-1206. PubMed ID: 32878481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Transmission and the Risk of Aerosol-Generating Procedures.
    Pasnick S; Carlos WG; Dela Cruz CS; Gross JE; Garrison G; Jamil S
    Am J Respir Crit Care Med; 2020 Aug; 202(4):P13-P14. PubMed ID: 32795140
    [No Abstract]   [Full Text] [Related]  

  • 40. Prediction of the Transition From Subexponential to the Exponential Transmission of SARS-CoV-2 in Chennai, India: Epidemic Nowcasting.
    Krishnamurthy K; Ambikapathy B; Kumar A; Britto L
    JMIR Public Health Surveill; 2020 Sep; 6(3):e21152. PubMed ID: 32609621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.